Marcin Sumila

Dose-intensified Versus Conventional-dose Salvage Radiotherapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: The SAKK 09/10 Randomized Phase 3 Trial.

P. Wust, J. Bernhard, G. Hildebrandt, 2021, European urology.

Use of EORTC target definition guidelines for dose-intensified salvage radiation therapy for recurrent prostate cancer: results of the quality assurance program of the randomized trial SAKK 09/10.

P. Manser, G. Hildebrandt, M. Guckenberger, 2013, International journal of radiation oncology, biology, physics.

Importance and outcome relevance of central pathology review in prostatectomy specimens: data from the SAKK 09/10 randomized trial on prostate cancer

V. Budach, G. Hildebrandt, M. Guckenberger, 2017, BJU international.

Acute Toxicity and Quality of Life After Dose-Intensified Salvage Radiation Therapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: First Results of the Randomized Trial SAKK 09/10.

P. Wust, J. Bernhard, G. Hildebrandt, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Dose-response relationship for breast cancer induction at radiotherapy dose

U. Schneider, A. Mack, G. Gruber, 2011, Radiation oncology.

Site-specific dose-response relationships for cancer induction from the combined Japanese A-bomb and Hodgkin cohorts for doses relevant to radiotherapy

U. Schneider, M. Sumila, Judith Robotka, 2011, Theoretical Biology and Medical Modelling.

Estimation of second cancer risk after radiotherapy for rectal cancer: comparison of 3D conformal radiotherapy and volumetric modulated arc therapy using different high dose fractionation schemes

U. Schneider, G. Gruber, D. Zwahlen, 2016, Radiation oncology.

Radiation-induced second malignancies after involved-node radiotherapy with deep-inspiration breath-hold technique for early stage Hodgkin Lymphoma: a dosimetric study

U. Schneider, G. Gruber, D. Weber, 2014, Radiation oncology.

Development of whole-body representation and dose calculation in a commercial treatment planning system

U. Schneider, Choonsik Lee, M. Mille, 2021, Zeitschrift fur medizinische Physik.

Predictive factors for response to salvage stereotactic body radiotherapy in oligorecurrent prostate cancer limited to lymph nodes: a single institution experience

U. Schneider, R. Cathomas, D. Zwahlen, 2019, BMC Urology.

Erectile function preservation after salvage radiation therapy for biochemically recurrent prostate cancer after prostatectomy: Five-year results of the SAKK 09/10 randomized phase 3 trial

M. Beck, P. Ghadjar, T. Hölscher, 2024, Clinical and Translational Radiation Oncology.